These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19041787)

  • 1. Is new hope on the horizon for obesity?
    Bray GA
    Lancet; 2008 Nov; 372(9653):1859-1860. PubMed ID: 19041787
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacological treatment of obesity: past, present and future].
    Simonyi G; Pados G; Medvegy M; Bedros JR
    Orv Hetil; 2012 Mar; 153(10):363-73. PubMed ID: 22370224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficiency and safety of pharmacological approaches to the management of obesity.
    Hainer V
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S349-54. PubMed ID: 21525481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 5. [New drugs for the treatment of obesity].
    Mustajoki P
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract]   [Full Text] [Related]  

  • 6. The war against obesity: attacking a new front.
    Klein S
    Am J Clin Nutr; 1999 Jun; 69(6):1061-3. PubMed ID: 10357721
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is there a future for medical treatment of obesity?].
    Richelsen B
    Ugeskr Laeger; 2009 Oct; 171(41):2973. PubMed ID: 19814923
    [No Abstract]   [Full Text] [Related]  

  • 8. Tesofensine and weight loss.
    Sommet A; Pathak A; Montastruc JL
    Lancet; 2009 Feb; 373(9665):719; author reply 720. PubMed ID: 19249626
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.
    Astrup A; Madsbad S; Breum L; Jensen TJ; Kroustrup JP; Larsen TM
    Lancet; 2008 Nov; 372(9653):1906-1913. PubMed ID: 18950853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].
    Nielsen AL; Larsen TM; Madsbad S; Breum L; Jensen TJ; Kroustrup JP; Astrup A
    Ugeskr Laeger; 2009 Oct; 171(41):2974-7. PubMed ID: 19824222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug treatment of obesity].
    Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
    Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of obesity with liraglutide. NN8022-1807 study].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2010 Aug; 51(8):1064-6. PubMed ID: 20628715
    [No Abstract]   [Full Text] [Related]  

  • 13. Orlistat on plasma lipids and body weight reduction: A really effective drug?
    Khazaei S; Hanis SM; Mansori K
    Pharmacol Res; 2017 Sep; 123():26. PubMed ID: 28648737
    [No Abstract]   [Full Text] [Related]  

  • 14. Tesofensine, a monoamine reuptake inhibitor for the treatment of obesity.
    Bello NT; Zahner MR
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1105-16. PubMed ID: 19777399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current treatment of obesity].
    Pados G
    Orv Hetil; 2010 Mar; 151(12):501-4. PubMed ID: 20231134
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of tesofensine on appetite sensations.
    Gilbert JA; Gasteyger C; Raben A; Meier DH; Astrup A; Sjödin A
    Obesity (Silver Spring); 2012 Mar; 20(3):553-61. PubMed ID: 21720440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where can I find information on the use of human chorionic gonadotrophin (HCG) for weight loss?
    Cunningham E
    J Am Diet Assoc; 2010 Dec; 110(12):1960. PubMed ID: 21111102
    [No Abstract]   [Full Text] [Related]  

  • 18. Tesofensine and weight loss.
    Tsai AG
    Lancet; 2009 Feb; 373(9665):719; author reply 720. PubMed ID: 19249625
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tesofensine--a novel potent weight loss medicine. Evaluation of: Astrup A, Breum L, Jensen TJ, Kroustrup JP, Larsen TM. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1906-13.
    Doggrell SA
    Expert Opin Investig Drugs; 2009 Jul; 18(7):1043-6. PubMed ID: 19548858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.